BAMM — Body and Mind Share Price
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -273.45% | ||
| Return on Equity | n/a | ||
| Operating Margin | -72.36% | ||
Financial Summary
| Year End 31st Jul | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 4.61 | 5.29 | 26.9 | 23.37 | 22.82 | n/a | n/a | 56.73% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Body and Mind Inc. is a Canada-based operations - focused cannabis company which operates retail cannabis dispensaries in California and Illinois with pending retail operations in New Jersey. The Company's segments include Retail and All others. The Company's products include flowers, pre rolls and hemp blunts, concentrates, carts and vapes, and edibles. Its featured products include Krispy Bites, Pretzel Bites and Chocolate Bites. It manages and operates a BaM Body and Mind branded dispensary including cultivation in West Memphis, Arkansas. It owns and operates The Reef by Body and Mind retail dispensary in the limited license jurisdiction of Seaside, California. The Company's subsidiary is DEP Nevada Inc.
Directors
- Michael Mills PRE (51)
- Dong Shim CFO (37)
- Stephen Hoffman COO (56)
- Darren Tindale SEC (48)
- Alexis Podesta DRC (40)
- Brent Reuter IND (53)
- David Wenger IND (39)
- Last Annual
- July 31st, 2023
- Last Interim
- April 30th, 2024
- Incorporated
- September 15th, 2010
- Public Since
- December 22nd, 2011
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 149,008,674
- Address
- 750 - 1095 West Pender Street, VANCOUVER, V6E 2M6
- Web
- https://bodyandmind.com/about/
- Phone
- +1 6043763567
- Contact
- Michael Mills
- Auditors
- Sadler, Gibb & Associates, LLC
Upcoming Events for BAMM
Q2 2025 Body and Mind Inc Earnings Release
Q3 2025 Body and Mind Inc Earnings Release
Similar to BAMM
1933 Industries
Canadian Securities Exchange
1CM
Canadian Securities Exchange
Adastra Holdings
Canadian Securities Exchange
Aion Therapeutic
Canadian Securities Exchange
Asia Green Biotechnology
Canadian Securities Exchange
FAQ
What is the Body and Mind share price?
As of Today at 19:39 UTC, shares in Body and Mind are trading at CA$0.03. This share price information is delayed by 15 minutes.
How has the Body and Mind share price performed this year?
Shares in Body and Mind last closed at CA$0.03 and the price had moved by -72.22% over the past 365 days. In terms of relative price strength the Body and Mind share price has underperformed the Toronto Stock Exchange 300 Composite Index by -75.64% over the past year.
What are the analyst and broker recommendations for Body and Mind?
There is no consensus recommendation for this security.
Find out moreWhat is the Body and Mind dividend yield?
Body and Mind does not currently pay a dividend.
Does Body and Mind pay a dividend?
Body and Mind does not currently pay a dividend.
When does Body and Mind next pay dividends?
Body and Mind does not currently pay a dividend.
How do I buy Body and Mind shares?
To buy shares in Body and Mind you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Body and Mind?
As of the previous close price of CA$0.03, shares in Body and Mind had a market capitalisation of .
Where are Body and Mind shares listed?
Here are the trading details for Body and Mind:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: BAMM
What kind of share is Body and Mind?
Based on an overall assessment of its quality, value and momentum Body and Mind is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Body and Mind share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Body and Mind share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Body and Mind. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -46.17%.
As of the last closing price of CA$0.03, shares in Body and Mind were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Body and Mind PE Ratio?
The Body and Mind PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.03.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Body and Mind?
Body and Mind's management team is headed by:
- Michael Mills - PRE
- Dong Shim - CFO
- Stephen Hoffman - COO
- Darren Tindale - SEC
- Alexis Podesta - DRC
- Brent Reuter - IND
- David Wenger - IND